✦ LIBER ✦

The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—Can it rule out clinically significant prostate cancer?

✍ Scribed by Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Charman, Susan C.; Anastasiadis, Eleni; Freeman, Alex; Emberton, Mark; Kirkham, Alex

Book ID: 121342233
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 227 KB
Volume: 32
Category: Article
ISSN: 1078-1439
DOI: 10.1016/j.urolonc.2013.06.007

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1441 THE ROLE OF MULTIPARAMETRIC MRI IN

1441 THE ROLE OF MULTIPARAMETRIC MRI IN MEN WITH NEGATIVE BIOPSY AND ELEVATED PSA - CAN IT RULE OUT CLINICALLY SIGNIFICANT DISEASE?

✍ Abd Alazeez, Mohamed; Ahmed, Hashim U.; Moore, Caroline; Freeman, Alex; Allen, C 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 49 KB

The significance of prostatic specific a

The significance of prostatic specific antigen in men with prostate disease: An elevated PSA level may indicate prostate cancer—and it may not

✍ Jane Wozniak-Petrofsky 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 175 KB

Combination of the preoperative PSA leve

Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer

✍ Anthony V D’Amico; Richard Whittington; S.Bruce Malkowicz; Yue Hui Wu; Ming-Hui 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Multiparametric magnetic resonance imagi

Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy

✍ Alessandro Sciarra; Valeria Panebianco; Susanna Cattarino; Gian Maria Busetto; E 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

Can multiparametric magnetic resonance i

Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St Peter׳s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.

✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 415 KB